Czynniki ryzyka chorób układu krążenia (CHUK) u dorosłych mieszkańców Krakowa i całej Polski. Wyniki badania WOBASZ i polskiej części projektu HAPIEE

Agnieszka Doryńska(Institute of Cardiology), Andrzej Pająk(Jagiellonian University), Krystyna Kozakiewicz(Medical University of Silesia), Walerian Piotrowski, Krystyna Szafraniec(Jagiellonian University), Jerzy Piwoński(de Duve Institute), Tomasz Zdrojewski(Gdańsk Medical University), Magdalena Kozela(Jagiellonian University), Wojciech Drygas(Medical University of Lodz), Andrzej Tykarski(Poznan University of Medical Sciences), Maciej Polak(Jagiellonian University), Wojciech Bielecki(Medical University of Lodz)
Unknown
January 1, 2015
Cited by 0

Related Papers

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
|The Lancet|2021|3.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
|The Lancet|2024|873
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|713
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|The Lancet Diabetes & Endocrinology|2016|391